128 related articles for article (PubMed ID: 19943130)
21. Search for residual prostate cancer on pT0 radical prostatectomy after positive biopsy.
Mazzucchelli R; Barbisan F; Tagliabracci A; Lopez-Beltran A; Cheng L; Scarpelli M; Montironi R
Virchows Arch; 2007 Apr; 450(4):371-8. PubMed ID: 17285325
[TBL] [Abstract][Full Text] [Related]
22. Transurethral resection of the prostate for patients with Gleason score 6 prostate cancer and symptomatic prostatic enlargement: a risk-adaptive strategy for the era of active surveillance.
Koo KC; Park SU; Rha KH; Hong SJ; Yang SC; Hong CH; Chung BH
Jpn J Clin Oncol; 2015 Aug; 45(8):785-90. PubMed ID: 25979243
[TBL] [Abstract][Full Text] [Related]
23. Incidental prostatic cancer: repeat TURP or biopsy?
Martino P; Palazzo S; Battaglia M; Lucarelli G; Selvaggi FP
Urol Int; 2004; 73(3):193-7. PubMed ID: 15539835
[TBL] [Abstract][Full Text] [Related]
24. HER2 expression and gene amplification in pT2a Gleason score 6 prostate cancer incidentally detected in cystoprostatectomies: comparison with clinically detected androgen-dependent and androgen-independent cancer.
Montironi R; Mazzucchelli R; Barbisan F; Stramazzotti D; Santinelli A; Scarpelli M; Lòpez Beltran A
Hum Pathol; 2006 Sep; 37(9):1137-44. PubMed ID: 16938518
[TBL] [Abstract][Full Text] [Related]
25. Thrombospondin-1 expression in patients with pathologic stage T3 prostate cancer undergoing radical prostatectomy: association with p53 alterations, tumor angiogenesis, and tumor progression.
Grossfeld GD; Carroll PR; Lindeman N; Meng M; Groshen S; Feng AC; Hawes D; Cote RJ
Urology; 2002 Jan; 59(1):97-102. PubMed ID: 11796289
[TBL] [Abstract][Full Text] [Related]
26. Subclassification of clinical stage T1 prostate cancer: impact on biochemical recurrence following radical prostatectomy.
Magheli A; Rais-Bahrami S; Carter HB; Peck HJ; Epstein JI; Gonzalgo ML
J Urol; 2007 Oct; 178(4 Pt 1):1277-80; discussion 1280-1. PubMed ID: 17698121
[TBL] [Abstract][Full Text] [Related]
27. MUC1 expression in human prostate cancer cell lines and primary tumors.
O'Connor JC; Julian J; Lim SD; Carson DD
Prostate Cancer Prostatic Dis; 2005; 8(1):36-44. PubMed ID: 15477874
[TBL] [Abstract][Full Text] [Related]
28. The impact of prior TURP on radical prostatectomy surgical margins: a multicenter analysis.
Gacci M; Simonato A; Lanciotti M; Ennas M; Varca V; Maffezzini M; Imbimbo C; Gontero P; Schiavina R; Carini M; Martorana G; Nicita G; Mirone V; Carmignani G
Urol Int; 2013; 91(1):62-8. PubMed ID: 23735440
[TBL] [Abstract][Full Text] [Related]
29. Loss of PTEN Expression Detected by Fluorescence Immunohistochemistry Predicts Lethal Prostate Cancer in Men Treated with Prostatectomy.
Hamid AA; Gray KP; Huang Y; Bowden M; Pomerantz M; Loda M; Sweeney CJ
Eur Urol Oncol; 2019 Sep; 2(5):475-482. PubMed ID: 31411988
[TBL] [Abstract][Full Text] [Related]
30. Expression of MUC1 and sialyl-Tn in benign prostatic glands, high-grade prostate intraepithelial neoplasia and malignant prostatic glands: a preliminary study.
Garbar C; Mascaux C; Wespes E
Anal Quant Cytol Histol; 2008 Apr; 30(2):71-7. PubMed ID: 18561742
[TBL] [Abstract][Full Text] [Related]
31. The prognostic value of pretreatment expression of androgen receptor and bcl-2 in hormonally treated prostate cancer patients.
Noordzij MA; Bogdanowicz JF; van Krimpen C; van der Kwast TH; van Steenbrugge GJ
J Urol; 1997 Nov; 158(5):1880-4; discussion 1884-5. PubMed ID: 9334622
[TBL] [Abstract][Full Text] [Related]
32. The prognostic role of ERG immunopositivity in prostatic acinar adenocarcinoma: a study including 454 cases and review of the literature.
Xu B; Chevarie-Davis M; Chevalier S; Scarlata E; Zeizafoun N; Dragomir A; Tanguay S; Kassouf W; Aprikian A; Brimo F
Hum Pathol; 2014 Mar; 45(3):488-97. PubMed ID: 24406017
[TBL] [Abstract][Full Text] [Related]
33. Down-Regulation of S100A8 is an Independent Predictor of PSA Recurrence in Prostate Cancer Treated by Radical Prostatectomy.
Minner S; Hager D; Steurer S; Höflmayer D; Tsourlakis MC; Möller-Koop C; Clauditz TS; Hube-Magg C; Luebke AM; Simon R; Sauter G; Göbel C; Weidemann S; Lebok P; Dum D; Fraune C; Izbicki J; Burandt E; Schlomm T; Huland H; Heinzer H; Haese A; Graefen M; Heumann A
Neoplasia; 2019 Sep; 21(9):872-881. PubMed ID: 31382165
[TBL] [Abstract][Full Text] [Related]
34. [Incidental prostate cancer: volume, location and degree of differentiation of the tumor in the radical prostatectomy specimen and value of subclassification to stage A1 and A2].
Voges GE; McNeal JE; Stamey TA
Urologe A; 1991 Nov; 30(6):401-9. PubMed ID: 1722922
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of paneth cell-like neuroendocrine differentiation in adenocarcinoma of the prostate.
Tamas EF; Epstein JI
Am J Surg Pathol; 2006 Aug; 30(8):980-5. PubMed ID: 16861969
[TBL] [Abstract][Full Text] [Related]
36. Predicting prostate carcinoma volume and stage at radical prostatectomy by assessing needle biopsy specimens for percent surface area and cores positive for carcinoma, perineural invasion, Gleason score, DNA ploidy and proliferation, and preoperative serum prostate specific antigen: a report of 454 cases.
Sebo TJ; Cheville JC; Riehle DL; Lohse CM; Pankratz VS; Myers RP; Blute ML; Zincke H
Cancer; 2001 Jun; 91(11):2196-204. PubMed ID: 11391602
[TBL] [Abstract][Full Text] [Related]
37. A review of radical prostatectomy from three centres in the UK: clinical presentation and outcome.
Feneley MR; Gillatt DA; Hehir M; Kirby RS
Br J Urol; 1996 Dec; 78(6):911-8; discussion 919-20. PubMed ID: 9014719
[TBL] [Abstract][Full Text] [Related]
38. Forkhead protein FKHR and its phosphorylated form p-FKHR in human prostate cancer.
Li R; Erdamar S; Dai H; Wheeler TM; Frolov A; Scardino PT; Thompson TC; Ayala GE
Hum Pathol; 2007 Oct; 38(10):1501-7. PubMed ID: 17597184
[TBL] [Abstract][Full Text] [Related]
39. [Diagnosis and treatment of incidental prostate cancer following TUPVP (a report of 15 cases)].
Gu X; Zhu Q; Zhang P; Zhang Y; Lu Z; Xu Y; Huang S
Zhonghua Nan Ke Xue; 2004 Nov; 10(11):849-50, 854. PubMed ID: 15595689
[TBL] [Abstract][Full Text] [Related]
40. Expression levels of heat shock protein 27 and cellular FLICE-like inhibitory protein in prostate cancer correlate with Gleason score sum and pathologic stage.
Lee SW; Cho JM; Cho HJ; Kang JY; Kim EK; Yoo TK
Korean J Urol; 2015 Jul; 56(7):505-14. PubMed ID: 26175869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
